메뉴 건너뛰기
Journal of Virology
Volumn 89, Issue 13, 2015, Pages 6711-6724
Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors
Author keywords

[No Author keywords available]
Indexed keywords

LASSA VIRUS GLYCOPROTEIN PRECURSOR; ONCOLYTIC VESICULAR STOMATITIS VIRUS; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;
EID: 84930894282     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00709-15     Document Type: Article
Times cited : (31)
References (61)
  • 2
    • 0036787611 scopus 로고    scopus 로고
    • Epidemiology of primary brain tumors: current concepts and review of the literature
    • Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. 2002. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278-299. http://dx.doi.org/10.1093/neuonc/4.4.278.
    • (2002) Neuro Oncol , vol.4 , pp. 278-299
    • Wrensch, M.1    Minn, Y.2    Chew, T.3    Bondy, M.4    Berger, M.S.5
  • 3
    • 0031975369 scopus 로고    scopus 로고
    • Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma
    • Sampson JH, Carter JH, Jr, Friedman AH, Seigler HF. 1998. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88:11-20. http://dx.doi.org/10.3171/jns.1998.88.1.0011.
    • (1998) J Neurosurg , vol.88 , pp. 11-20
    • Sampson, J.H.1    Carter Jr, J.H.2    Friedman, A.H.3    Seigler, H.F.4
  • 4
    • 0033929057 scopus 로고    scopus 로고
    • Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
    • Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N, Bell JC. 2000. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nature Med 6:821-825. http://dx .doi.org/10.1038/77558.
    • (2000) Nature Med , vol.6 , pp. 821-825
    • Stojdl, D.F.1    Lichty, B.2    Knowles, S.3    Marius, R.4    Atkins, H.5    Sonenberg, N.6    Bell, J.C.7
  • 5
    • 84869217555 scopus 로고    scopus 로고
    • Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer
    • Hastie E, Grdzelishvili V. 2012. Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer. J Gen Virol 93:2529-2545. http://dx.doi.org/10.1099/vir.0.046672-0.
    • (2012) J Gen Virol , vol.93 , pp. 2529-2545
    • Hastie, E.1    Grdzelishvili, V.2
  • 6
    • 0033646858 scopus 로고    scopus 로고
    • Vesicular stomatitis virus (VSV) therapy of tumors
    • Balachandran S, Barber GN. 2000. Vesicular stomatitis virus (VSV) therapy of tumors. IUBMB Life 50:135-138. http://dx.doi.org/10.1080/713803696.
    • (2000) IUBMB Life , vol.50 , pp. 135-138
    • Balachandran, S.1    Barber, G.N.2
  • 9
    • 22944458202 scopus 로고    scopus 로고
    • Altering the tropism of lentiviral vectors through pseudotyping
    • Cronin J, Zhang XY, Reiser J. 2005. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5:387-398. http://dx.doi .org/10.2174/1566523054546224.
    • (2005) Curr Gene Ther , vol.5 , pp. 387-398
    • Cronin, J.1    Zhang, X.Y.2    Reiser, J.3
  • 10
    • 79956119782 scopus 로고    scopus 로고
    • Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism
    • Muik A, Kneiske I, Werbizki M, Wilflingseder D, Giroglou T, Ebert O, Kraft A, Dietrich U, Zimmer G, Momma S, von Laer D. 2011. Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J Virol 85:5679-5684. http://dx.doi.org/10.1128/JVI.02511-10.
    • (2011) J Virol , vol.85 , pp. 5679-5684
    • Muik, A.1    Kneiske, I.2    Werbizki, M.3    Wilflingseder, D.4    Giroglou, T.5    Ebert, O.6    Kraft, A.7    Dietrich, U.8    Zimmer, G.9    Momma, S.10    von Laer, D.11
  • 12
    • 0023693714 scopus 로고
    • Non-lethal infection of aminergic reticular core neurons: age-dependent spread of ts mutant vesicular stomatitis virus from the nose
    • Lundh B, Löve A, Kristensson K, Norrby E. 1988. Non-lethal infection of aminergic reticular core neurons: age-dependent spread of ts mutant vesicular stomatitis virus from the nose. J Neuropathol Exp Neurol 47: 497-506. http://dx.doi.org/10.1097/00005072-198809000-00001.
    • (1988) J Neuropathol Exp Neurol , vol.47 , pp. 497-506
    • Lundh, B.1    Löve, A.2    Kristensson, K.3    Norrby, E.4
  • 13
    • 0036147372 scopus 로고    scopus 로고
    • Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein
    • van den Pol AN, Dalton KP, Rose JK. 2002. Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. J Virol 76:1309-1327. http://dx.doi.org/10.1128/JVI.76.3.1309-1327.2002.
    • (2002) J Virol , vol.76 , pp. 1309-1327
    • van den Pol, A.N.1    Dalton, K.P.2    Rose, J.K.3
  • 14
    • 0032897970 scopus 로고    scopus 로고
    • Attenuated vesicular stomatitis viruses as vaccine vectors
    • Roberts A, Buonocore L, Price R, Forman J, Rose JK. 1999. Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol 73:3723-3732.
    • (1999) J Virol , vol.73 , pp. 3723-3732
    • Roberts, A.1    Buonocore, L.2    Price, R.3    Forman, J.4    Rose, J.K.5
  • 15
    • 0034968098 scopus 로고    scopus 로고
    • Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development
    • Flanagan EB, Zamparo JM, Ball LA, Rodriguez LL, Wertz GW. 2001. Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development. J Virol 75:6107-6114. http://dx.doi.org/10.1128/JVI.75.13.6107-6114.2001.
    • (2001) J Virol , vol.75 , pp. 6107-6114
    • Flanagan, E.B.1    Zamparo, J.M.2    Ball, L.A.3    Rodriguez, L.L.4    Wertz, G.W.5
  • 16
    • 7444243792 scopus 로고    scopus 로고
    • Sensitivity of prostate tumors to wild-type and M protein mutant vesicular stomatitis viruses
    • Ahmed M, Cramer SD, Lyles DS. 2004. Sensitivity of prostate tumors to wild-type and M protein mutant vesicular stomatitis viruses. Virology 330:34-49. http://dx.doi.org/10.1016/j.virol.2004.08.039.
    • (2004) Virology , vol.330 , pp. 34-49
    • Ahmed, M.1    Cramer, S.D.2    Lyles, D.S.3
  • 17
    • 29744444477 scopus 로고    scopus 로고
    • A vesicular stomatitis virus recombinant expressing granulocyte- macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals
    • Ramsburg E, Publicover J, Buonocore L, Poholek A, Robek M, Palin A, Rose JK. 2005. A vesicular stomatitis virus recombinant expressing granulocyte- macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. J Virol 79: 15043-15053. http://dx.doi.org/10.1128/JVI.79.24.15043-15053.2005.
    • (2005) J Virol , vol.79 , pp. 15043-15053
    • Ramsburg, E.1    Publicover, J.2    Buonocore, L.3    Poholek, A.4    Robek, M.5    Palin, A.6    Rose, J.K.7
  • 18
    • 33846799429 scopus 로고    scopus 로고
    • Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations andNgene translocations
    • Clarke DK, Nasar F, Lee M, Johnson JE, Wright K, Calderon P, Guo M, Natuk R, Cooper D, Hendry RM, Udem SA. 2007. Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations andNgene translocations. J Virol 81:2056-2064. http://dx.doi.org/10.1128/JVI.01911-06.
    • (2007) J Virol , vol.81 , pp. 2056-2064
    • Clarke, D.K.1    Nasar, F.2    Lee, M.3    Johnson, J.E.4    Wright, K.5    Calderon, P.6    Guo, M.7    Natuk, R.8    Cooper, D.9    Hendry, R.M.10    Udem, S.A.11
  • 19
    • 37349122809 scopus 로고    scopus 로고
    • Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and G gene truncation reduces neurovirulence and enhances immunogenicity in mice
    • Cooper D, Wright KJ, Calderon PC, Guo M, Nasar F, Johnson JE, Coleman JW, Lee M, Kotash C, Yurgelonis I, Natuk RJ, Hendry RM, Udem SA, Clarke DK. 2008. Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and G gene truncation reduces neurovirulence and enhances immunogenicity in mice. J Virol 82:207-219. http://dx.doi.org/10.1128/JVI.01515-07.
    • (2008) J Virol , vol.82 , pp. 207-219
    • Cooper, D.1    Wright, K.J.2    Calderon, P.C.3    Guo, M.4    Nasar, F.5    Johnson, J.E.6    Coleman, J.W.7    Lee, M.8    Kotash, C.9    Yurgelonis, I.10    Natuk, R.J.11    Hendry, R.M.12    Udem, S.A.13    Clarke, D.K.14
  • 20
    • 73949087549 scopus 로고    scopus 로고
    • Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells
    • Wollmann G, Rogulin V, Simon I, Rose JK, van den Pol AN. 2010. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. J Virol 84:1563-1573. http://dx.doi.org/10.1128/JVI.02040-09.
    • (2010) J Virol , vol.84 , pp. 1563-1573
    • Wollmann, G.1    Rogulin, V.2    Simon, I.3    Rose, J.K.4    van den Pol, A.N.5
  • 21
    • 84871968468 scopus 로고    scopus 로고
    • Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity
    • van den Pol AN, Davis JN. 2013. Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity. J Virol 87:1019-1034. http://dx.doi.org/10.1128/JVI.01106-12.
    • (2013) J Virol , vol.87 , pp. 1019-1034
    • van den Pol, A.N.1    Davis, J.N.2
  • 23
    • 84870613982 scopus 로고    scopus 로고
    • Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a filovirus entry receptor
    • Krishnan A, Miller EH, Herbert AS, Ng M, Ndungo E, Whelan SP, Dye JM, Chandran K. 2012. Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a filovirus entry receptor. Viruses 4:2471-2484. http://dx.doi.org/10.3390/v4112471.
    • (2012) Viruses , vol.4 , pp. 2471-2484
    • Krishnan, A.1    Miller, E.H.2    Herbert, A.S.3    Ng, M.4    Ndungo, E.5    Whelan, S.P.6    Dye, J.M.7    Chandran, K.8
  • 24
    • 64849106106 scopus 로고    scopus 로고
    • Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction
    • Kunz S. 2009. Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction. Virology 387:245-249. http://dx.doi.org/10.1016/j.virol.2009.02.042.
    • (2009) Virology , vol.387 , pp. 245-249
    • Kunz, S.1
  • 25
    • 84876926824 scopus 로고    scopus 로고
    • LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
    • Finkelshtein D, Werman A, Novick D, Barak S, Rubinstein M. 2013. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Nat Acad Sci U S A 110:7306-7311. http://dx.doi.org/10.1073/pnas.1214441110.
    • (2013) Proc Nat Acad Sci U S A , vol.110 , pp. 7306-7311
    • Finkelshtein, D.1    Werman, A.2    Novick, D.3    Barak, S.4    Rubinstein, M.5
  • 28
    • 0036113626 scopus 로고    scopus 로고
    • Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins
    • Watson DJ, Kobinger GP, Passini MA, Wilson JM, Wolfe JH. 2002. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 5:528-537. http://dx.doi.org/10.1006/mthe.2002.0584.
    • (2002) Mol Ther , vol.5 , pp. 528-537
    • Watson, D.J.1    Kobinger, G.P.2    Passini, M.A.3    Wilson, J.M.4    Wolfe, J.H.5
  • 29
    • 84868141217 scopus 로고    scopus 로고
    • A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence
    • Papaneri AB, Wirblich C, Cann JA, Cooper K, Jahrling PB, Schnell MJ, Blaney JE. 2012. A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence. Virology 434:18-26. http://dx.doi.org/10.1016/j.virol.2012.07.020.
    • (2012) Virology , vol.434 , pp. 18-26
    • Papaneri, A.B.1    Wirblich, C.2    Cann, J.A.3    Cooper, K.4    Jahrling, P.B.5    Schnell, M.J.6    Blaney, J.E.7
  • 31
    • 72849133481 scopus 로고    scopus 로고
    • A forward genetic strategy reveals destabilizing mutations in the ebolavirus glycoprotein that alter its protease dependence during cell entry
    • Wong AC, Sandesara RG, Mulherkar N, Whelan SP, Chandran K. 2010. A forward genetic strategy reveals destabilizing mutations in the ebolavirus glycoprotein that alter its protease dependence during cell entry. J Virol 84:163-175. http://dx.doi.org/10.1128/JVI.01832-09.
    • (2010) J Virol , vol.84 , pp. 163-175
    • Wong, A.C.1    Sandesara, R.G.2    Mulherkar, N.3    Whelan, S.P.4    Chandran, K.5
  • 33
    • 19144365133 scopus 로고    scopus 로고
    • Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
    • Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. http://dx.doi.org/10.1126/science.1110656.
    • (2005) Science , vol.308 , pp. 1643-1645
    • Chandran, K.1    Sullivan, N.J.2    Felbor, U.3    Whelan, S.P.4    Cunningham, J.M.5
  • 34
    • 2342455182 scopus 로고    scopus 로고
    • Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses
    • Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Möller P, Wagner R, Volchkov V, Klenk HD, Feldmann H, Ströher U. 2004. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol 78:5458-5465. http://dx .doi.org/10.1128/JVI.78.10.5458-5465.2004.
    • (2004) J Virol , vol.78 , pp. 5458-5465
    • Garbutt, M.1    Liebscher, R.2    Wahl-Jensen, V.3    Jones, S.4    Möller, P.5    Wagner, R.6    Volchkov, V.7    Klenk, H.D.8    Feldmann, H.9    Ströher, U.10
  • 35
    • 78149305588 scopus 로고    scopus 로고
    • The length of vesicular stomatitis virus particles dictates a need for actin assembly during clathrin-dependent endocytosis
    • Cureton DK, Massol RH, Whelan SP, Kirchhausen T. 2010. The length of vesicular stomatitis virus particles dictates a need for actin assembly during clathrin-dependent endocytosis. PLoS Pathog 6:e1001127. http://dx.doi.org/10.1371/journal.ppat.1001127.
    • (2010) PLoS Pathog , vol.6 , pp. e1001127
    • Cureton, D.K.1    Massol, R.H.2    Whelan, S.P.3    Kirchhausen, T.4
  • 37
    • 39749183412 scopus 로고    scopus 로고
    • Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain
    • Ozduman K, Wollmann G, Piepmeier J, van den Pol AN. 2008. Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain. J Neurosci 28:1882-1893. http://dx.doi.org/10.1523/JNEUROSCI.4905-07.2008.
    • (2008) J Neurosci , vol.28 , pp. 1882-1893
    • Ozduman, K.1    Wollmann, G.2    Piepmeier, J.3    van den Pol, A.N.4
  • 38
    • 84878607022 scopus 로고    scopus 로고
    • Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes
    • Wollmann G, Davis JN, Bosenberg MW, van den Pol AN. 2013. Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes. J Virol 87:6644-6659. http://dx.doi .org/10.1128/JVI.03311-12.
    • (2013) J Virol , vol.87 , pp. 6644-6659
    • Wollmann, G.1    Davis, J.N.2    Bosenberg, M.W.3    van den Pol, A.N.4
  • 39
    • 84895443386 scopus 로고    scopus 로고
    • Long distance interferon signaling within the brain blocks virus spread
    • van den Pol AN, Ding S, Robek MD. 2014. Long distance interferon signaling within the brain blocks virus spread. J Virol 88:3695-3704. http://dx.doi.org/10.1128/JVI.03509-13.
    • (2014) J Virol , vol.88 , pp. 3695-3704
    • van den Pol, A.N.1    Ding, S.2    Robek, M.D.3
  • 40
    • 33846553509 scopus 로고    scopus 로고
    • Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells
    • Wollmann G, Robek MD, van den Pol AN. 2007. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells. J Virol 81:1479-1491. http://dx.doi.org/10.1128/JVI.01861-06.
    • (2007) J Virol , vol.81 , pp. 1479-1491
    • Wollmann, G.1    Robek, M.D.2    van den Pol, A.N.3
  • 41
    • 37048998555 scopus 로고    scopus 로고
    • Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells
    • Waibler Z, Detje CN, Bell JC, Kalinke U. 2007. Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells. Immunobiology 212:887-894. http://dx.doi.org/10.1016/j.imbio.2007.09.003.
    • (2007) Immunobiology , vol.212 , pp. 887-894
    • Waibler, Z.1    Detje, C.N.2    Bell, J.C.3    Kalinke, U.4
  • 42
    • 70350289814 scopus 로고    scopus 로고
    • Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain
    • Ozduman K, Wollmann G, Ahmadi SA, van den Pol AN. 2009. Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain. J Virol 83:11540 -11549. http://dx.doi.org/10.1128/JVI.02558-08.
    • (2009) J Virol , vol.83 , pp. 11540 -11549
    • Ozduman, K.1    Wollmann, G.2    Ahmadi, S.A.3    van den Pol, A.N.4
  • 43
    • 0042208208 scopus 로고    scopus 로고
    • Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity
    • Obuchi M, Fernandez M, Barber GN. 2003. Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity. J Virol 77:8843-8856. http://dx.doi .org/10.1128/JVI.77.16.8843-8856.2003.
    • (2003) J Virol , vol.77 , pp. 8843-8856
    • Obuchi, M.1    Fernandez, M.2    Barber, G.N.3
  • 44
    • 84888352952 scopus 로고    scopus 로고
    • Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV
    • Yarde DN, Naik S, Nace RA, Peng KW, Federspiel MJ, Russell SJ. 2013. Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV. Cancer Gene Ther 20:616-621. http://dx.doi.org/10.1038/cgt.2013.63.
    • (2013) Cancer Gene Ther , vol.20 , pp. 616-621
    • Yarde, D.N.1    Naik, S.2    Nace, R.A.3    Peng, K.W.4    Federspiel, M.J.5    Russell, S.J.6
  • 45
    • 0035935255 scopus 로고    scopus 로고
    • Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration
    • Phuangsab A, Lorence RM, Reichard KW, Peeples ME, Walter RJ. 2001. Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration. Cancer Lett 172:27-36. http://dx.doi.org/10.1016/S0304-3835(01)00617-6.
    • (2001) Cancer Lett , vol.172 , pp. 27-36
    • Phuangsab, A.1    Lorence, R.M.2    Reichard, K.W.3    Peeples, M.E.4    Walter, R.J.5
  • 46
    • 0032526693 scopus 로고    scopus 로고
    • The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus
    • Strong JE, Coffey MC, Tang D, Sabinin P, Lee PW. 1998. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 17:3351-3362. http://dx.doi.org/10.1093/emboj/17.12.3351.
    • (1998) EMBO J , vol.17 , pp. 3351-3362
    • Strong, J.E.1    Coffey, M.C.2    Tang, D.3    Sabinin, P.4    Lee, P.W.5
  • 47
    • 11144324185 scopus 로고    scopus 로고
    • Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier
    • Wang F, Ma Y, Barrett JW, Gao X, Loh J, Barton E, Virigin HW, McFadden G. 2004. Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nature Immunol 5:1266-1274. http://dx.doi.org/10.1038/ni1132.
    • (2004) Nature Immunol , vol.5 , pp. 1266-1274
    • Wang, F.1    Ma, Y.2    Barrett, J.W.3    Gao, X.4    Loh, J.5    Barton, E.6    Virigin, H.W.7    McFadden, G.8
  • 48
    • 84859447241 scopus 로고    scopus 로고
    • Treatment of melanoma brain metastases: a new paradigm
    • Carlino MS, Fogarty GB, Long GV. 2012. Treatment of melanoma brain metastases: a new paradigm. Cancer J 18:208-212. http://dx.doi.org/10.1097/PPO.0b013e31824b2890.
    • (2012) Cancer J , vol.18 , pp. 208-212
    • Carlino, M.S.1    Fogarty, G.B.2    Long, G.V.3
  • 49
    • 80052475970 scopus 로고    scopus 로고
    • Vesicular stomatitis virus has extensive oncolytic activity against human sarcomas: rare resistance is overcome by blocking interferon pathways
    • Paglino JC, van den Pol AN. 2011. Vesicular stomatitis virus has extensive oncolytic activity against human sarcomas: rare resistance is overcome by blocking interferon pathways. J Virol 85:9346-9358. http://dx .doi.org/10.1128/JVI.00723-11.
    • (2011) J Virol , vol.85 , pp. 9346-9358
    • Paglino, J.C.1    van den Pol, A.N.2
  • 50
    • 4143118912 scopus 로고    scopus 로고
    • Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses
    • Publicover J, Ramsburg E, Rose JK. 2004. Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses. J Virol 78:9317-9324. http://dx.doi.org/10.1128/JVI.78.17.9317-9324.2004.
    • (2004) J Virol , vol.78 , pp. 9317-9324
    • Publicover, J.1    Ramsburg, E.2    Rose, J.K.3
  • 51
    • 80052507771 scopus 로고    scopus 로고
    • Activating systemic T-Cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus
    • Wongthida P, Diaz RM, Pulido C, Rommelfanger D, Galivo F, Kaluza K, Kottke T, Thompson J, Melcher A, Vile R. 2011. Activating systemic T-Cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus. Hum Gene Ther 22:1343-1353. http://dx.doi.org/10.1089/hum.2010.216.
    • (2011) Hum Gene Ther , vol.22 , pp. 1343-1353
    • Wongthida, P.1    Diaz, R.M.2    Pulido, C.3    Rommelfanger, D.4    Galivo, F.5    Kaluza, K.6    Kottke, T.7    Thompson, J.8    Melcher, A.9    Vile, R.10
  • 52
    • 0027954320 scopus 로고
    • Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis
    • Huneycutt BS, Plakhov IV, Shusterman Z, Bartido SM, Huang A, Reiss CS, Aoki C. 1994. Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis. Brain Res 635:81-95. http://dx.doi.org/10.1016/0006-8993(94)91426-5.
    • (1994) Brain Res , vol.635 , pp. 81-95
    • Huneycutt, B.S.1    Plakhov, I.V.2    Shusterman, Z.3    Bartido, S.M.4    Huang, A.5    Reiss, C.S.6    Aoki, C.7
  • 53
    • 84912561989 scopus 로고    scopus 로고
    • Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector
    • Wollmann G, Paglino JC, Maloney PR, Ahmadi SA, van den Pol AN. 2015. Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector. Virology 475:1-14. http://dx.doi.org/10.1016/j.virol.2014.10.035.
    • (2015) Virology , vol.475 , pp. 1-14
    • Wollmann, G.1    Paglino, J.C.2    Maloney, P.R.3    Ahmadi, S.A.4    van den Pol, A.N.5
  • 54
    • 0025873586 scopus 로고
    • Intracellular distribution of input vesicular stomatitis virus proteins after uncoating
    • Rigaut KD, Birk DE, Lenard J. 1991. Intracellular distribution of input vesicular stomatitis virus proteins after uncoating. J Virol 65:2622-2628.
    • (1991) J Virol , vol.65 , pp. 2622-2628
    • Rigaut, K.D.1    Birk, D.E.2    Lenard, J.3
  • 55
    • 84863717012 scopus 로고    scopus 로고
    • Activation of a glioma-specific immune response by oncolytic parvovirus minute virus of mice infection
    • Grekova SP, Raykov Z, Zawatzky R, Rommelaere J, Koch U. 2012. Activation of a glioma-specific immune response by oncolytic parvovirus minute virus of mice infection. Cancer Gene Ther 19:468-475. http://dx .doi.org/10.1038/cgt.2012.20.
    • (2012) Cancer Gene Ther , vol.19 , pp. 468-475
    • Grekova, S.P.1    Raykov, Z.2    Zawatzky, R.3    Rommelaere, J.4    Koch, U.5
  • 56
    • 27144515268 scopus 로고    scopus 로고
    • A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector
    • Publicover J, Ramsburg E, Rose JK. 2005. A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector. J Virol 79: 13231-13238. http://dx.doi.org/10.1128/JVI.79.21.13231-13238.2005.
    • (2005) J Virol , vol.79 , pp. 13231-13238
    • Publicover, J.1    Ramsburg, E.2    Rose, J.K.3
  • 57
    • 0036635723 scopus 로고    scopus 로고
    • Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins
    • Buonocore L, Blight KJ, Rice CM, Rose JK. 2002. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol 76:6865-6872. http://dx .doi.org/10.1128/JVI.76.14.6865-6872.2002.
    • (2002) J Virol , vol.76 , pp. 6865-6872
    • Buonocore, L.1    Blight, K.J.2    Rice, C.M.3    Rose, J.K.4
  • 59
    • 77950517857 scopus 로고    scopus 로고
    • Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses
    • Abraham J, Corbett KD, Farzan M, Choe H, Harrison SC. 2010. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat Struct Mol Biol 17:438-444. http://dx.doi.org/10.1038/nsmb.1772.
    • (2010) Nat Struct Mol Biol , vol.17 , pp. 438-444
    • Abraham, J.1    Corbett, K.D.2    Farzan, M.3    Choe, H.4    Harrison, S.C.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.